The new Integrated Care Boards have formed across England and we look in this session to review the implications of this and how key documents such as the ‘Fuller Report’ will influence how diabetes care is delivered in this new structure.

Integrated systems of working are going to be key to delivering population health-focused interventions and we will look to some case studies showing integrated care being delivered by pharmacists in diabetes.

There is good evidence for improved outcomes e.g., safety and cost efficacy and we hope to share some of this supportive evidence.  

• To understand how the new ICB structure may affect diabetes care in the next few years
• To think about how we deliver more integrated care
• To look at any supporting evidence for integrated working in diabetes care